Cannell Thomas R

Orexigen Therapeutics, Inc.

EVP, COO, Pres Global Com Prod

Avg. Two Year Performance

No Purchase Track Record

No Sale Track Record

Holdings: 3.88K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions